|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 1/02 | (2006.01) |
| A01N 1/0247 | (2013.01) | ||
| A61M 1/36 | (2006.01) | ||
| A01N 1/0226 | (2013.01) | ||
| A61M 1/3623 | (2022.05) |
| (11) | Number of the document | 3698630 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20169811.5 |
| Date of filing the European patent application | 2014-12-01 | |
| (97) | Date of publication of the European application | 2020-08-26 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201314095621 | 2013-12-03 | US |
| (72) |
POTENZIANO, Jim , US
HANSELL, Douglas R , US
GRIEBEL, Jeff , US
COSTA, Eddie , US
COOPER, Lisa , US
|
| (73) |
Mallinckrodt Pharmaceuticals Ireland Limited ,
College Business & Technology Park
Cruiserath, Blanchardstown, Dublin 15,
IE
|
| (54) | ADMINISTRATION AND MONITORING OF NITRIC OXIDE IN EX VIVO FLUIDS |
| ADMINISTRATION AND MONITORING OF NITRIC OXIDE IN EX VIVO FLUIDS |